Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Obsessive-Compulsive Disorder Marketed and Pipeline Drugs Report Overview

Obsessive-compulsive disorder (OCD) is a disorder where repetitive behaviors such as hand washing/cleaning, checking on things, mental acts like counting, or other activities can significantly interfere with a person’s daily activities and social interactions. Although the cause of OCD is not very clear, certain genetic factors like a mutation in the human serotonin transporter gene (hSERT) can trigger OCD, as can several environmental factors, autoimmune disorders such as pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS), parental influence, and family rituals.

The OCD marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing, and reimbursement, late-to-mid-stage pipeline products with phase transition success rate (PTSR), and the likelihood of approval (LoA) for OCD.

Obsessive-Compulsive Disorder Marketed Drugs Segmentation by Mechanism of Action

The key mechanisms of action for OCD marketed drugs are transporter inhibitor, receptor agonist, and receptor antagonist. The mechanism of action for most marketed drugs for OCD is transporter inhibitor.

Obsessive-Compulsive Disorder Marketed Drugs Analysis by MoA, 2023 (%)

For more MoA insights into OCD marketed drugs, download a free report sample

OCD Marketed Drugs Segmentation by Routes of Administration

The key routes of administration for OCD marketed drugs are oral and injection. Most marketed drugs for OCD are small molecule oral therapies, followed by injectables.

Obsessive-Compulsive Disorder Marketed Drugs Analysis by RoA, 2023 (%)

For more RoA insights into the OCD marketed drugs, download a free report sample

Obsessive-Compulsive Disorder Pipeline Drugs Segmentation by Mechanisms of Action

The key mechanisms of action for OCD pipeline drugs are receptor antagonist, receptor agonist, enzyme inhibitor, cytotoxic to cell, and transporter activator. Most of the OCD pipeline drugs are receptor agonists.

Obsessive-Compulsive Disorder Pipeline Drugs Analysis by MoA, 2023 (%)

For more MoA insights into the OCD pipeline drugs market, download a free report sample

OCD Pipeline Drugs Segmentation by Routes of Administration

The key routes of administration for OCD pipeline drugs are oral, injection, and topical. The pipeline drugs for OCD are mostly oral drugs, followed by injectables.

Obsessive-Compulsive Disorder Pipeline Drugs Analysis by RoA, 2023 (%)

For more RoA insights into the OCD pipeline drugs market, download a free report sample

Most of the pipeline drugs for OCD are small molecules. Biologic is the other significant molecule type in the pipeline drugs for OCD.

Obsessive-Compulsive Disorder Pipeline Drugs Analysis by Molecule Types, 2023 (%)

For more molecule type insights into the OCD pipeline drugs market, download a free report sample

Top Sponsors in the OCD Marketed and Pipeline Drugs Market

Some of the top sponsors in the OCD marketed and pipeline drugs market are Tehran University of Medical Sciences, Mashhad University of Medical Sciences, New York State Psychiatric Institute, Shiraz University of Medical Sciences, Iran University of Medical Sciences, Shanghai Mental Health Center, Isfahan University of Medical Sciences, and Kurdistan University of Medical Sciences. Non-commercial sponsors dominated the clinical trials space in OCD over the past 10 years with Tehran University of Medical Sciences sponsoring the highest number of clinical trials overall, followed by Mashhad University of Medical Sciences.

Obsessive-Compulsive Disorder Pipeline Drugs Market Report Overview

Obsessive-Compulsive Disorder Pipeline Drugs Market Report Overview

Segments Covered in the Report

OCD Marketed Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)

• Receptor Antagonist
• Transporter Inhibitor
• Receptor Agonist

OCD Marketed Drugs Routes of Administration Outlook (Number of Drugs, 2023)

• Oral
• Injection

OCD Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)

• Receptor Antagonist
• Receptor Agonist
• Enzyme Inhibitor
• Cytotoxic to Cell
• Transporter Activator

OCD Pipeline Drugs Routes of Administration Outlook (Number of Drugs, 2023)

• Injection
• Oral
• Topical

OCD Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)

• Small Molecule
• Biologic

Scope

Scope

GlobalData’s Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape combine data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include:

• Disease Landscape
• Disease Overview
• Epidemiology Overview
• Treatment Overview
• Marketed Products Assessment
• Breakdown by Mechanism of Action, Molecule Type, Route of Administration
• Product Profiles with Sales Forecast
• Pricing and Reimbursement Assessment
• Annual Therapy Cost
• Time to Pricing and Time to Reimbursement
• Pipeline Assessment
• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
• Product Profiles with Sales Forecast
• Late-to-mid-stage Pipeline Drugs
• Phase Transition Success Rate and Likelihood of Approval
• Clinical Trials Assessment
• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
• Enrolment Analytics, Site Analytics, Feasibility Analysis
• Deals Landscape
• Mergers, Acquisitions, and Strategic Alliances by Region
• Overview of Recent Deals
• Commercial Assessment
• Key Market Players
• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the OCD market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global OCD market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.